Radalbuvir

DB12065InvestigationalSmall molecule

Radalbuvir has been used in trials studying the treatment of Chronic Hepatitis C, Chronic HCV Infection, and Chronic Hepatitis C Infection.

Mechanism: Pharmacologically active on RNA-directed RNA polymerase
Curator reviewed
Formula / weight: C₃₀H₄₁NO₆S · 543.72 g/mol (avg)
Code names: Gs-9669

Resolves to

Compound

Structure

InChIKeyMUICUPWICXUNRS-GDCCIXDYSA-NSMILESCC1=CC[C@@H](CC1)C(=O)N([C@H]1CC[C@](O)(CO[C@H]2CCOC2)CC1)C1=C(SC(=C1)C#CC(C)(C)C)C(O)=O

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Radalbuvir, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.